Loading quotes...
Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
West Pharmaceutical reports cyberattack and temporary operational disruptions
West Pharmaceutical discovered a cyberattack on May 4 in which data were exfiltrated and systems were encrypted. The company shut down systems worldwide, notified law enforcement and hired IT forensics experts; key systems have already been partially restored and shipping, goods receipt and manufacturing have resumed at some sites. Recovery is still ongoing at other locations, there is no timetable for full restoration, and the financial impact cannot currently be quantified. » More on de.investing.com
West Pharmaceutical raises forecast and outlines growth strategy at Wells‑Fargo conference
West Pharmaceutical raised its organic revenue growth forecast for 2025 from 2–3% to 3–4% and increased the EPS forecast by $0.50 after strong demand for GLP‑1 components and drug delivery systems. CFO Bob McMahon emphasized operational strength, the focus on SmartDose to improve profitability (including automation or divestiture options), and investments in contract manufacturing in the US and Ireland. The company expects capacity expansions and contract manufacturing to have a positive impact on free cash flow from 2026 and sees mid‑term HVP growth in the mid‑ to high‑single digits to low‑double digits. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | August 2026 | YoY |
|---|---|---|
| Revenue | 147.15M | 0.22% |
| Gross profit | 57.65M | 12.37% |
| Net profit | 30.84M | 15.78% |
| EBITDA | 49.81M | 17.71% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €439.4M |
Number of shares | 39.66M |
52-week high/low | €18.46 - €7.30 |
Dividend yield | 4.61% |
Dividends TTM | €0.55 |
Next dividend | €0.20 |
Beta | 0.74 |
P/E ratio | 9.68 |
PEG ratio | 0.19 |
P/B ratio | 1.88 |
P/S ratio | 1.37 |
Company profile
West Holdings Corporation engages in the renewable energy business. It is involved in the installation of residential and industrial solar power generation systems; ground-based and roof-based installations for factories; construction and sales of public and industrial photovoltaic power generation systems; solar power generation and sales activities; management and maintenance business for photovoltaic power generation systems and related equipment; and energy saving services. The company was founded in 1981 and is headquartered in Tokyo, Japan.
| Name | West Holdings |
| CEO | Takashi Kikkawa |
| Headquarters | Hiroshima,
hi Japan |
| Website | |
| IPO | 06/24/2004 |
| Employees | 341 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Japan Exchange Group | 1407.T |